Researchers at the University of Oulu describe how they used the E4 to develop a model that predicts migraine attacks using biosignals.
The migraine is a chronic, incapacitating neurovascular disorder, characterized by attacks of severe headache and autonomic nervous system dysfunction, concerning 15% of people in developed countries. It is one of the most understated and incapacitating diseases in the world and costing yearly 111 Billion Euros in Europe only. However, the driving force to start this study was Heli’s son who started to have migraine attacks since he was 2-year-old.
The focus was on early detection of the attacks by using human measured biosignals. Empatica E4 was selected to be used in the study as it is the most capable device in the market, containing more sensors than any other wrist-worn device, and it has been found reliable in the previous studies as well. By using it, the aim was to develop a model that assists individuals to take their medication on time and hence help to avoid the pain in migraine.
